scholarly journals Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival

BMC Cancer ◽  
2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Fei Sun ◽  
Wen Ding ◽  
Jie-Hua He ◽  
Xiao-Jing Wang ◽  
Ze-Biao Ma ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Patient Survival ◽  
Poor Patient ◽  
Poor Patient Survival

Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival

2011 ◽  
Vol 59 (6) ◽  
pp. 1163-1172 ◽  
Author(s):  
Fung Zhao ◽  
Michelle K Y Siu ◽  
LiLi Jiang ◽  
Kar Fai Tam ◽  
Hextan Y S Ngan ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Patient Survival ◽  
Aggressive Phenotype ◽  
Poor Patient ◽  
Poor Patient Survival

scholarly journals Loss of ANXA7 Expression is Associated with Poor Patient Survival in Ovarian Cancer

2011 ◽  
Vol 02 (04) ◽  
Author(s):  
Meera Srivastava ◽  
Ofer Eidelman ◽  
Lukas Bubendorf ◽  
Harvey B. Pollard
Keyword(s):  
Ovarian Cancer ◽  
Patient Survival ◽  
Poor Patient ◽  
Poor Patient Survival

Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival

2014 ◽  
Vol 52 (5) ◽  
Author(s):  
Feng Zhou ◽  
Guohua Tao ◽  
Xiang Chen ◽  
Wei Xie ◽  
Manhua Liu ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Patient Survival ◽  
Poor Patient ◽  
Cancer Tissues ◽  
Poor Patient Survival

scholarly journals Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance

PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e113478 ◽  
Author(s):  
Fung Zhao ◽  
Michelle K. Y. Siu ◽  
LiLi Jiang ◽  
Kar Fai Tam ◽  
Hextan Y. S. Ngan ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Patient Survival ◽  
Paclitaxel Resistance ◽  
Forkhead Box ◽  
Poor Patient ◽  
Poor Patient Survival

scholarly journals Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival

2017 ◽  
Vol 16 (6) ◽  
pp. 8842-8848 ◽  
Author(s):  
Lei Guo ◽  
Jianjiang Zheng ◽  
Tao Yu ◽  
Yuequan Liu ◽  
Lukun Duo
Keyword(s):  
Patient Survival ◽  
Poor Patient ◽  
Elevated Expression ◽  
Poor Patient Survival

Lamins as cancer biomarkers

2010 ◽  
Vol 38 (1) ◽  
pp. 297-300 ◽  
Author(s):  
Clare R. Foster ◽  
Stefan A. Przyborski ◽  
Robert G. Wilson ◽  
Christopher J. Hutchison
Keyword(s):  
Cancer Cells ◽  
Patient Survival ◽  
Cancer Biomarkers ◽  
Tumour Cells ◽  
Diagnostic Biomarkers ◽  
Cancer Subtypes ◽  
Multifunctional Proteins ◽  
Poor Patient ◽  
Poor Patient Survival

Lamins are multifunctional proteins that are often aberrantly expressed or localized in tumours. Here, we endeavour to assess their uses as cancer biomarkers: to diagnose tumours, analyse cancer characteristics and predict patient survival. It appears that the nature of lamin function in cancer is very complex. Lamin expression can be variable between and even within cancer subtypes, which limits their uses as diagnostic biomarkers. Expression of A-type lamins is a marker of differentiated tumour cells and has been shown to be a marker of good or poor patient survival depending on tumour subtype. Further research into the functions of lamins in cancer cells and the mechanisms that determine its patterns of expression may provide more potential uses of lamins as cancer biomarkers.

Sign in / Sign up

Export Citation Format

Share Document